Table 3 Characterization of hASCs.
Antigen | Surface protein | FBS | HS |
|---|---|---|---|
CD14 | Serum lipopolysaccharide-binding protein | 2.6 ± 2.7 | 1.1 ± 1.0 |
CD19 | B lymphocyte-lineage differentiation antigen | 1.1 ± 0.9 | 0.4 ± 0.1 |
CD34 | Sialomucin-like adhesion molecule | 19.6 ± 12.2 | 27.4 ± 23.5 |
CD45 | Leukocyte common antigen | 1.5 ± 0.8 | 1.8 ± 1.6 |
CD49d | Integrin a2, VLA-4 | 12.7 ± 2.5 | 35.4 ± 10.1 |
CD73 | Ecto-50-nucleotidase | 82.2 ± 8.5 | 85.9 ± 7.3 |
CD90 | Thy-1 (T cell surface glycoprotein) | 97.3 ± 2.5 | 96.5 ± 4.6 |
CD105 | SH-2, endoglin | 85.3 ± 17.7 | 79.2 ± 21.1 |
CD106 | VCAM-1 (vascular cell adhesion molecule) | 0.6 ± 0.3 | 1.3 ± 1.7 |
HLA-ABC | Major histocompatibility class I antigens | 16.9 ± 8.1 | 28.1 ± 16.4 |
HLA-DR | Major histocompatibility class II antigens | 1.9 ± 1.2 | 1.0 ± 1.0 |